Q&A
-
Permission granted by Josh Makower
Q&AFriday Q&A: Stanford Biodesign’s Makower on expediting Medicare coverage for breakthrough devices
The director and co-founder of the Stanford Byers Center for Biodesign has been urging CMS to get patients access to breakthrough devices.
By Susan Kelly • Updated May 26, 2023 -
Permission granted by Boston Scientific
Q&AFriday Q&A: Boston Scientific’s De Rosa on the rise of an AFib ‘game changer’
The Switzerland-based vice president of rhythm management for Europe, the Middle East and Africa expects a “massive shift” to pulsed field ablation from other atrial fibrillation treatments.
By Susan Kelly • May 5, 2023 -
Permission granted by Texas Innovation Center
Q&AFriday Q&A: J&J’s Shan Jegatheeswaran talks about the ‘behind the scenes’ work of AI in medtech
The global head of digital solutions for J&J’s medtech unit says the intersection between software and how it’s used is an important, and often overlooked, aspect of AI.
By Elise Reuter • April 28, 2023 -
Permission granted by Abbott
Q&AFriday Q&A: Abbott’s Vish Charan on muscling into the leadless pacemaker market
Abbott is taking on Medtronic in the market for wireless devices to treat abnormally slow heart rhythms.
By Susan Kelly • April 21, 2023 -
Permission granted by Medtronic
Q&AFriday Q&A: Medtronic’s Ajizian talks connected care ahead of unit spinoff
From supporting AI-driven medical interventions to freeing up providers from administrative tasks, remote patient monitoring is raising the bar for care, says Medtronic’s CMO for patient monitoring.
By Susan Kelly • April 15, 2023 -
Permission granted by Movano
Q&AFriday Q&A: Movano takes on the women’s wearables market with a smart ring
Movano Health aims to stand out from the wearables crowd with a women’s health focus and strategy that is centered on obtaining FDA clearances.
By Susan Kelly • March 24, 2023 -
Permission granted by Hyfe
Q&AFriday Q&A: A startup founder tackles the riddle of why we cough
Joe Brew, the founder of three-year-old Hyfe, sees the potential for cough-tracking technology to be as ubiquitous as blood-pressure cuffs.
By Susan Kelly • March 17, 2023 -
Permission granted by Erik Vollebregt
Q&AFriday Q&A: A regulatory attorney breaks down the EU MDR transition
Amsterdam-based regulatory expert Erik Vollebregt explains the agreement this week to extend the deadlines to comply with the EU’s Medical Device Regulation, and the issues that still need to be addressed.
By Susan Kelly • March 10, 2023 -
Permission granted by GE HealthCare
Q&AFriday Q&A: GE HealthCare’s Yoder on using AI to drive precision care
The healthcare technology and diagnostics firm, now a standalone company, will integrate the acquisition of AI software developer Caption Health under Yoder’s lead.
By Susan Kelly • Feb. 23, 2023 -
Courtesy of Medtronic
Q&AFriday Q&A: Medtronic’s Chan talks patient monitoring spinoff, rise of home care
As more patients are moved out of expensive hospital beds, Medtronic sees a growing market for remote care in homes and long-term care facilities.
By Elise Reuter • Feb. 2, 2023 -
Courtesy of GE Healthcare
Q&AFriday Q&A: For GE HealthCare, the future is digital, CEO Arduini says
Digital capabilities will be “the next big inflection” driving growth for GE’s newly independent healthcare business.
By Peter Green • Jan. 6, 2023 -
Permission granted by Freenome
Q&AFreenome CEO Mike Nolan talks colorectal cancer test, clinical trials
The San Francisco-based company recently enrolled a clinical trial for its blood-based cancer test but faces competition in the market for minimally invasive cancer tests.
By Elise Reuter • Dec. 22, 2022 -
Johnny Greig via Getty Images
The 10 biggest medtech stories of 2022
MedTech Dive reporting this year has explored how companies maintained momentum even amid supply shortages and rising inflation rates.
By MedTech Dive staff • Dec. 3, 2022 -
Permission granted by Tissium
Q&AMedTech Innovators: Tissium co-founder Maria Pereira on taking tech from bench to bedside
The MIT-trained scientist explains how she went from PhD candidate to startup founder whose company is preparing to commercialize a range of products for use in reconstructing damaged tissue.
By Susan Kelly • Nov. 30, 2022 -
Permission granted by Embecta
Q&AFriday Q&A: Embecta CEO talks BD spinoff, future of diabetes devices
Dev Kurdikar spoke with MedTech Dive about developing an insulin pump for patients with Type 2 diabetes and what’s next for the firm.
By Elise Reuter • Nov. 18, 2022 -
Courtesy of GE Healthcare
Q&AFriday Q&A: GE HealthCare’s Shetty on building accurate AI tools
The executive, who leads the company’s effort to create an integrated suite of AI tools for hospitals, warns against overloading clinicians with unconnected information.
By Elise Reuter • Nov. 11, 2022 -
Permission granted by Brittany Barreto
Q&AFriday Q&A: FemTech Focus’s Barreto discusses women’s health innovations, funding challenges
The executive director of the nonprofit group explains why women's health is finally getting attention and what the FemTech revolution is all about.
By Susan Kelly • Nov. 4, 2022
